Olink

Olink®
Part of Thermo Fisher Scientific

Filters

PublicationDisease areaApplication areaSample typeProducts

Advanced Science, 2026
Caspase‐3/GSDME‐Mediated Trophoblast Pyroptosis and Reciprocal Macrophage Polarization Contribute to Inflammation in Early‐Onset Preeclampsia

Huang B., Deng W., Bi S. et al.

Olink Explore 3072/384ObstetricsPathophysiologyPlasma

Advanced Healthcare Materials, 2026
Uncovering the Adaptive Tumor Immunity Interactions from a Single‐Cell Level

Liu T., Pang Y., Zhou C. et al.

Olink Target 96 MouseOncologyTechnical EvaluationMouse Cell Supernatant

Molecular Therapy, 2026
Dyslipidemia-associated natural IgM improves oncolytic virus TILT-123 efficacy through antibody-dependent enhancement in solid tumors

Clubb J., Pakola S., Joenväärä S. et al.

Olink Target 96OncologyImmunotherapyPathophysiologySerum

Molecular Therapy, 2026
Dyslipidemia-associated natural IgM improves oncolytic virus TILT-123 efficacy through antibody-dependent enhancement in solid tumors

Clubb J., Pakola S., Joenväärä S. et al.

Olink Target 96OncologyImmunotherapyPathophysiologySerum

Signal Transduction and Targeted Therapy, 2026
Multiomics Mendelian randomization identifies serpin family G member 1 as a chronic obstructive pulmonary disease modulator

Yi E., Cui J., Wang H. et al.

Olink Explore 3072/384Respiratory DiseasesPathophysiologyPlasma

Cardiovascular Diabetology, 2026
Chronic kidney disease onset, progression, and cardiovascular outcomes: proteomics informs biology and risk stratification

Zhang J., Yu H., Song X. et al.

Olink Explore 3072/384CVDNephrologyPathophysiologyPatient StratificationPlasma

Bioinformatics Advances, 2026
HDAnalyzeR: Streamlining Data Analysis for Biomarker Research

Antonopoulos K., Johansson E., Kenrick J. et al.

Olink Explore 3072/384OncologyWider Bioinformatics StudiesData SciencePlasma

European Stroke Journal, 2026
Elevated acute-phase plasma levels of S100A12 [EN-RAGE] are associated with vascular recurrence after ischemic stroke

Granelli B., Angerfors A., Furutjäll S. et al.

Olink Target 96CVDNeurologyPatient StratificationPlasma

Annals of Neurology, 2026
Neutrophil‐Secreted Enzymes and ALS Risk: Exploring a Potential Mechanistic Link

Cao W., Yu L., Wang Z. et al.

Olink Explore 3072/384NeurologyPathophysiologyPlasma

Bone, 2026
Association between systemic redox balance and osteoporosis: prospective evidence, polygenic modification, and proteomic and inflammatory mediation in the UK Biobank

Zhu Y., Liu D., Yin X. et al.

Olink Explore 3072/384OrthopedicsPathophysiologyPlasma

Annals of Hematology, 2026
Mendelian randomization analysis of immune cell subsets and inflammatory cytokines in aplastic anaemia

Hu K., Cheng Y., Xiao G. et al.

Olink Target 96HematologyPathophysiologyPlasma

Journal of Human Genetics, 2026
Meta-analyses of genome-wide association studies identify novel loci influencing Japanese white matter hyperintensities

Asanomi Y., Mitsumori R., Yamakawa A. et al.

Olink Target 96NeurologyAgingPathophysiologyPlasma

Molecular Therapy Advances, 2026
The first oral relaxin receptor RXFP1 agonist for heart failure treatment: Translational studies from non-human primates to humans

Ryberg E., Bergström F., Sten S. et al.

Olink Explore 3072/384CVDPathophysiologyMonkey Plasma

Medicine, 2026
Association of programmed cell death with atrial fibrillation risk: A multi-omics Mendelian randomization study

Liu K., Han X., Chen Y.

Olink Explore 3072/384CVDPathophysiologyPlasma

Microorganisms, 2026
Immune Dysregulation and Cytokine Profiling in Acute Mycoplasma pneumoniae Pneumonia

Wen Y., Zhai Y., Sang S. et al.

Olink Target 48 MouseInfectious DiseasesPathophysiologyMouse Balf

Biomedicine & Pharmacotherapy, 2026
Integrated transcriptomic and proteomic profiling identifies an interferon-dependent inflammatory endotype in sepsis

Fratea A., Riza A., Dumitrescu F. et al.

Olink Target 96Immunological & Inflammatory DiseasesPatient StratificationPlasma

Clinical Pharmacology in Drug Development, 2026
Safety, Tolerability, Pharmacokinetics, and Immunogenicity of a BTLA Agonist Antibody (Venanprubart) in Healthy Participants, Patients with Systemic Lupus Erythematosus, and Patients with Psoriasis: Results From Three Phase 1 Studies

Vendel A., Benichou O., Chang C. et al.

Olink Target 96Immunological & Inflammatory DiseasesPathophysiologySerum

Molecular Neurodegeneration Advances, 2026
Differential downstream signaling in microglia lacking Alzheimer’s-related TREM2 or its adaptor TYROBP/DAP12

Farias Quipildor G., Belfiore R., Althobaiti K. et al.

Olink Target 96 MouseNeurologyPathophysiologyMouse Cell Supernatant

Journal of Ethnopharmacology, 2026
OLink proteomic biomarker to predict clinical efficacy of Macaranga sinensis Müll.Arg: A nested case-control study

Chen G., Zhou S., Chen Y. et al.

Olink Target 96Infectious DiseasesPatient StratificationPlasma

Journal of Cachexia, Sarcopenia and Muscle, 2026
Integrated Proteomic and Metabolomic Profiling for Developing Novel Plasma‐Based Diagnostic Models of Sarcopenia

Xu D., Jin H., Yang J. et al.

Olink Explore 3072/384AgingPatient StratificationPlasma

3635 publications